Kieran
F.
Docherty
MD
Clinical Lecturer, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland
Disclosures
Dr Docherty’s employer, the University of Glasgow, has been remunerated by AstraZeneca for his work on clinical trials; he has received speaker fees from AstraZeneca, Boehringer Ingelheim, Pharmacosmos, Translational Medical Academy and Radcliffe Cardiology; has served on Advisory Boards for Us2.ai and holds equity in the company, has served on an advisory board and served on a clinical endpoint committee for Bayer AG;; and has received research grant support (paid to his institution) from AstraZeneca, Roche, Novartis and Boehringer Ingelheim.
